Orthocell Ltd - ESG Rating & Company Profile powered by AI
The ESG assessment for Orthocell Ltd indicates its transparency towards the UN Sustainable Development Goals. The ESG rating covers seventeen United Nations SDGs including: 'No Poverty', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. This analysis of Orthocell Ltd uses information from across the internet as well as from public disclosures by Orthocell Ltd.
Orthocell Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Orthocell Ltd | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Orthocell Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Orthocell Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Orthocell Ltd report the average age of the workforce?
Sign up for free to unlockDoes Orthocell Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Orthocell Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Orthocell Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Orthocell Ltd offer flexible work?
Sign up for free to unlockDoes Orthocell Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Orthocell Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Orthocell Ltd conduct supply chain audits?
Sign up for free to unlockDoes Orthocell Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Orthocell Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Orthocell Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Orthocell Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Orthocell Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Orthocell Ltd disclose water use targets?
Sign up for free to unlockDoes Orthocell Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Orthocell Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Orthocell Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Orthocell Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Orthocell Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Orthocell Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Orthocell Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Orthocell Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Orthocell Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Orthocell Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Orthocell Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Orthocell Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Orthocell Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Orthocell Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Orthocell Ltd disclose its waste policy?
Sign up for free to unlockDoes Orthocell Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Orthocell Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Orthocell Ltd disclose energy use targets?
Sign up for free to unlockDoes Orthocell Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Orthocell Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Orthocell Ltd
These potential risks are based on the size, segment and geographies of the company.
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.